Showing results (111-120 of 301) with videos related to
Sort By:
Pageof 31
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 8, 2012
Pretargeting: taking an alternate route for localizing radionuclidesRobert M Sharkey, Chien-Hsing Chang, Edmund A Rossi, et al.Arthritis Research & Therapy|April 25, 2006
Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosusThomas Dörner, Joerg Kaufmann, William A Wegener, et al.Molecular Cancer Therapeutics|July 24, 2014
Redirected T-cell killing of solid cancers targeted with an anti-CD3/Trop-2-bispecific antibody is enhanced in combination with interferon-αEdmund A Rossi, Diane L Rossi, Thomas M Cardillo, et al.Mabs|February 5, 2014
A new class of bispecific antibodies to redirect T cells for cancer immunotherapyDiane L Rossi, Edmund A Rossi, Thomas M Cardillo, et al.Oncotarget|March 25, 2020
Correction: Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)David M Goldenberg, Thomas M Cardillo, Serengulam V Govindan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electronsRosana B Michel, Adriane V Rosario, Philip M Andrews, et al.Nuclear Medicine and Biology|April 12, 2005
177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivoRosana B Michel, Philip M Andrews, Adriane V Rosario, et al.Bioconjugate Chemistry|August 3, 2011
High-yielding aqueous 18F-labeling of peptides via Al18F chelationChristopher A D'Souza, William J McBride, Robert M Sharkey, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2007
Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargetingDavid M Goldenberg, Edmund A Rossi, Robert M Sharkey, et al.Technology in Cancer Research & Treatment|July 21, 2005
Cancer therapy with radiolabeled and drug/toxin-conjugated antibodiesSerengulam V Govindan, Gary L Griffiths, Hans J Hansen, et al.Pageof 31